[
    "{\"step_by_step_thinking\": \"The documents highlight that the implementation of the 'test and treat' policy by the World Health Organization (WHO) will lead to an increased incidence of ART-related adverse effects, especially in sub-Saharan Africa. The region is characterized by extreme poverty, weak health systems, inadequate and low quality of health services, inaccessibility to existing health facilities, lack of qualified health personnel, lack of adequate equipment, inaccessibility and unaffordability of medicines, and heavy workload in a context of a double burden of disease. Additionally, there is a dearth of data on the incidence and predictive factors of ART-related adverse effects in sub-Saharan Africa. Therefore, it seems that the region is not yet prepared to manage the consequential increased burden of ART-related toxic and metabolic complications.\", \"answer_choice\": \"B. no\"}"
]